Big-deal Gilead rheumatoid arthritis drug rejected by FDA By: San Francisco Business Times via Business Journals August 19, 2020 at 11:28 AM EDT Filgotinib was the early centerpiece of Gilead's $5.1 billion expanded collaboration with Belgium's Galapagos NV. Read More >>